Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
N-(p-amylcinnamoyl) anthranilic acid
Cat. No.:
0225LY-1253
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
N-(p-amylcinnamoyl) anthranilic acid functions as a TRP channel blocker and a comprehensive inhibitor of Phospholipase A2 (PLA2).
Synonym:
ACA; 110683-10-8; N-(p-Amylcinnamoyl)anthranilic acid; n-(p-amylcinnamoyl) anthranilic acid; 4-Amylcinnamoylanthranilic acid; N-(4-Pentylcinnamoyl)anthranilic acid; p-Amylcinnamoylanthranilic acid; 2-(3-(4-Pentylphenyl)acrylamido)benzoic acid; BML264; aca; 2-[[(E)-3-(4-pentylphenyl)prop-2-enoyl]amino]benzoic acid; (E)-2-(3-(4-pentylphenyl)acrylamido)benzoic acid; Benzoic acid, 2-[[1-oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]-; 2-(((2E)-1-Oxo-3-(4-pentylphenyl)-2-propen-1-yl)amino)benzoic acid; Benzoic acid, 2-(((2E)-1-oxo-3-(4-pentylphenyl)-2-propen-1-yl)amino)-; Benzoic acid, 2-(((2E)-1-oxo-3-(4-pentylphenyl)-2-propenyl)amino)-
CAS No.:
110683-10-8
Compound CID:
5353376
Formula:
C21H23NO3
Formula Weight:
337.41
Specification
Relative Density:
1.178 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
N-(p-amylcinnamoyl) anthranilic acid can be used in ion channel research to study its role as a broad-spectrum TRP channel inhibitor.
Library Information
Target:
TRP channel; Phospholipase
Receptor:
PLA2; TRP/TRPV channel
Pathways:
Metabolism; Membrane transporter/Ion channel
Plate Number:
AOCL-17
Plate Location:
a10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
125 mg/mL; 370.47 mM
